跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Emzart 40 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Emzart 40
Approved
STANDARD
Emzart 40
Hetero Labs Limited (Unit V)
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
2e7dca54ff3730b7
Company
Hetero Labs Limited (Unit V)
Type
Standard
Approval Details
Approval Id
2e7dca54ff3730b7
Drug Approval Philippines Name
Emzart 40
Product Name
Emzart 40
Registration Number
DRP-10423-02
Brand Name
Emzart 40
Generic Name
Telmisartan
Dosage Form
Tablet
Dosage Strength
40 mg
Manufacturer
Hetero Labs Limited (Unit V)
Importer
Camber Pharmaceuticals, Inc.
Distributor
Emcure Pharma Philippines Inc
Importer Detail Path
/organization/camber-pharmaceuticals-inc
Issuance Date
29 March 2022
Expiry Date
25 October 2026
Pharmacologic Category
Angiotensin II Receptor Blocker (ARB)
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
2e7dca54ff3730b7
Type
Standard
Back to Philippines FDA Approvals